Research shows that people using GLP-1 therapy can unintentionally eat too little protein, fiber, or micronutrients (like calcium, magnesium, and vitamins A, D, E, and K) as appetite and total food intake decrease
Given that sensory or gastrointestinal adverse effects, such as dysgeusia and persistent nausea, can impair nutritional intake and lead to early treatment discontinuation (particularly in vulnerable populations) future research must incorporate rigorous sensory testing, larger and more diverse cohorts, and adherence-related outcomes to clarify how incretin therapies influence taste perception and long-term eating behavior (153, 157, 161)
Over the past three decades, poor health has contributed to a 2 to 3 percentage-point decline in U.S
Sterile tools support consistent outcomes during daily laboratory activities
If alcohol feels hard to control, talk with a healthcare provider
Those who have diabetes and metabolic syndrome often struggle to manage psoriasis symptoms